Applications of (R)-(-)-Amino-3-Hydroxybutanoic Acid in Industrial Manufacturing

As an original manufacturer of (R)-(-)-Amino-3-Hydroxybutanoic Acid, we supply this advanced chiral intermediate to specialized industries for the synthesis and development of value-added compounds. Our strict production controls and direct integration with downstream users ensure our material meets rigorous standards. Below are several key industrial applications supported by real-world regulatory and production demands.

1. Pharmaceutical Chiral Intermediate for β-Lactam Antibiotic Synthesis

Pharmaceutical plants utilize (R)-(-)-Amino-3-Hydroxybutanoic Acid as a critical precursor in the synthesis of advanced β-lactam antibiotic intermediates, especially in the side-chain assembly for carbapenem and penem derivatives. The chiral purity and batch traceability are essential for preparing active pharmaceutical ingredients where absolute stereochemistry impacts safety and efficacy. Strict monitoring of impurity profiles and validation of process reproducibility comply with international submission requirements.

Industry compliance standards

• ICH Q7 (GMP for Active Pharmaceutical Ingredients)
• USP/NF Monographs (applicable reference standards)
• European Pharmacopoeia (EP) guidelines for precursor substances
• US FDA cGMP 21 CFR Part 210/211

Typical usage ratio

• 0.8–1.3 molar equivalents relative to β-lactam core, adjusted for yield optimization and downstream reactivity

Downstream process integration

• Enters as a resolved chiral building block during the condensation and cyclization phases of small molecule synthesis
• Serves in the key step of side-chain attachment, immediately prior to ring closure or amidation
• Frequently introduced in the final API stage, followed by purification and salt formation

Final product types

• Thienamycin analogs (e.g., imipenem, meropenem)
• Synthesized β-lactam advanced intermediates
• Pharmaceutical APIs for injectable antibiotics

2. Chiral Synthesis Precursor in Novel Peptide Drug Development

Peptide manufacturing facilities use this compound to introduce defined stereochemistry into backbone-modified peptide drugs, particularly in research-scale and clinical-phase GMP campaigns. Its role as a non-canonical amino acid enables the formation of β-amino acids, peptides with controlled folding properties, and enhanced metabolic stability, key for next-generation therapeutic peptides. Documentation of enantiomeric excess and trace impurities is mandatory for investigational submission files.

Industry compliance standards

• ICH Q11 (Development and Manufacturing of Drug Substances)
• US DMF filing requirements for novel amino acids
• ICH Q3A (Impurities in New Drug Substances)
• ISO 9001:2015 QMS in peptide synthesis plants

Typical usage ratio

• 5–15 mol% at specific insertion sites in the peptide sequence, customized by target pharmacological effect and sequence design

Downstream process integration

• Activated via in situ coupling chemistry during automated or manual solid-phase peptide synthesis (SPPS)
• Protected as Fmoc-/Boc-derivatives for use in elongation cycles
• Isolation of target modified peptide, followed by HPLC purification and analytical verification

Final product types

• β-peptide injectable drug candidates
• Stabilized peptide derivatives for metabolic disease and oncology research
• Peptidomimetic libraries for preclinical screening

3. Enantiopure Building Block for Chiral Solvent and Catalyst Synthesis

Chemical synthesis plants incorporate (R)-(-)-Amino-3-Hydroxybutanoic Acid as a foundation material for producing tailor-made chiral auxiliaries and catalysts employed in enantioselective transformations, such as asymmetric hydrogenation and aldol reactions. Certifying its enantiomeric purity and chemical stability is critical, since these downstream products transfer chirality to high-value specialty chemicals. Documentation or audit trail of critical control points is necessary for customer-specific batch approval.

Industry compliance standards

• ISO 14001 (Environmental management, relevant for catalyst production)
• REACH compliance for registration of specialty chemicals in EU market
• CAS registration and SDS in line with GHS
• Internal QA/QC protocols for batch identity and residual solvent analysis

Typical usage ratio

• 10–40% weight in catalyst/auxiliary formulation, depending on downstream synthesis and efficiency demands

Downstream process integration

• Molecular backbone functionalization prior to auxiliary or ligand coupling
• Incorporated during reflux or protection/deprotection cycles for catalyst assembly
• Critical step in generating recoverable, recyclable chiral agents for industrial synthesis

Final product types

• Pyrrolidine or oxazolidinone-based chiral auxiliaries
• Enantioselective phase-transfer catalysts
• Bulk chiral solvents for fine chemical routes

4. Food Additive Precursor in Functional Nutraceutical Ingredient Production

Specialty food ingredient manufacturers apply (R)-(-)-Amino-3-Hydroxybutanoic Acid as a chiral precursor to synthesize advanced amino acid derivatives for functional food applications, including sports supplements and metabolic support blends. Traceability and allergen management are audited closely, and use as a precursor material must meet strict food safety standards. Routine monitoring of residual impurities and compliance with food-grade production are stipulated by national and international regulations.

Industry compliance standards

• GB 2760-2022 National Food Safety Standard (China)
• 21 CFR §172 (Food Additives Permitted for Direct Addition to Food for Human Consumption, US FDA)
• EC 1333/2008 (EU food additive regulation)
• HACCP and FSSC 22000 certification in production facilities

Typical usage ratio

• Up to 0.5% weight for precursor conversion, depending on target ingredient and conversion yield across synthesis steps

Downstream process integration

• Enters initial synthesis as a starting feedstock for functionalized amino acid or derivative conversion
• Intermediate isolation and purification to food-grade standards
• Blending into finished premixes and encapsulated forms following conversion

Final product types

• Nutraceutical supplement ingredients (e.g., β-Hydroxybutyrate salts derivatives)
• Metabolic support amino acid blends
• Sports nutrition drink premixes

5. Research Tool Compound for Life Science Analytical Standards

Commercial laboratories and reference material producers draw on (R)-(-)-Amino-3-Hydroxybutanoic Acid to develop analytical standards and calibration mixtures critical for chromatography, mass spectrometry, and enantioselective assay validation. Precision documentation of isotopic labeling, purity grade, and storage stability supports reliable quantitative and qualitative methods, essential to global pharmaceutical and food assay requirements.

Industry compliance standards

• ISO/IEC 17025 accreditation for reference material producers
• USP General Chapter <621> (Chromatography)
• Certificate of Analysis (CoA) traceable to NIST SRMs
• Documentation for chain of custody and material retention per ASTM E2973

Typical usage ratio

• Defined use at 100–500 µg/mL in calibration standard sets, optimized per instrument method and analytical technique

Downstream process integration

• Direct dissolution into certified solution or reference sample matrix
• Blending for multi-component, chiral reference standard sets
• Bottling to stability-tested containers for laboratory and field use

Final product types

• Enantiopure analytical reference standards
• Custom calibration mixtures for clinical or forensic labs
• Ready-to-use chiral assay reagents